Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
Monday, August 15, 2011 - 17:30
in Health & Medicine
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study.